Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,128 public trials 2,031 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

NCT04174196

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States
View Trial Details
Active, not recruiting

Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma

NCT04091126

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Westwood, Kansas, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Madison, Wisconsin, United States
  • GSK Investigational Site Newcastle, New South Wales, Australia
View all 30 locations
View Trial Details
Active, not recruiting

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02570542

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow up Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow Up Only) Montvale, New Jersey, United States
View all 14 locations
View Trial Details
Active, not recruiting

Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction

NCT03734198

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Chu Amiens Sud Amiens, France
  • CH Annecy Genevois - Hématologie A3 Annecy, France
  • CHU Jean Minjoz - Hématologie Besançon, France
  • Hôpital Avicenne - Centre de Recherche Clinique Bobigny, France
View all 24 locations
View Trial Details

Related conditions